Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials

BACKGROUND: Ertapenem, a new carbapenem with a favorable pharmacokinetic profile, has been approved for the treatment of complicated intra-abdominal Infections (cIAIs), acute pelvic infections (APIs) and complicated skin and skin-structure infections (cSSSIs). The aim of this study is to compare the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: An, Mao Mao, Zou, Zui, Shen, Hui, Zhang, Jun Dong, Chen, Meng Li, Liu, Ping, Wang, Rui, Jiang, Yuan Ying
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2009
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2794873/
https://ncbi.nlm.nih.gov/pubmed/19951447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-9-193
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia